Cargando…
Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
BACKGROUND: Neuromyelitis optica (NMO) is an immune-mediated inflammatory demyelinating disorder of the central nervous system with a predilection for the optic nerves and the spinal cord. Immunopathological evidence suggests that the target antigen of the disease is aquaporin-4. An IgG antibody aga...
Autores principales: | Unni, Narayanan, Barhate, Kavita, Ahmad, Nisha, Ganeshan, Malti, Singhal, Bhim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788284/ https://www.ncbi.nlm.nih.gov/pubmed/24101820 http://dx.doi.org/10.4103/0972-2327.116945 |
Ejemplares similares
-
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort
por: Barhate, Kavita Sohan, et al.
Publicado: (2014) -
Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
por: Jade, Jui Dilip, et al.
Publicado: (2017) -
NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006) -
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica
por: Chihara, Norio, et al.
Publicado: (2013) -
Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
por: Takeshita, Yukio, et al.
Publicado: (2016)